Adenocarcinoma of the pancreas
Clinical trials for Adenocarcinoma of the pancreas explained in plain language.
Never miss a new study
Get alerted when new Adenocarcinoma of the pancreas trials appear
Sign up with your email to follow new studies for Adenocarcinoma of the pancreas, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a Three-Drug combo crack pancreatic Cancer's defenses?
Disease control OngoingResearchers are testing whether adding two drugs to standard chemotherapy can shrink tumors and extend life in people with metastatic pancreatic cancer. Participants receive gemcitabine and nab-paclitaxel (standard chemo), plus cemiplimab (an immunotherapy approved for skin cance…
Matched conditions: ADENOCARCINOMA OF THE PANCREAS
Phase 2 • Sponsor: Columbia University • Aim: Disease control
Last updated Sep 21, 2026 23:00 UTC
-
Three-Drug immune cocktail takes on pancreatic cancer
Disease control PausedThis study tests whether combining three immunotherapy drugs (domvanalimab, zimberelimab, and APX005M) can safely control metastatic pancreatic cancer. The trial enrolls 46 people whose cancer has spread and standard treatments have stopped working. Researchers will monitor side …
Matched conditions: ADENOCARCINOMA OF THE PANCREAS
Phase 1/2 • Sponsor: James Cleary, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC